Varta
← Back to stories

From BusinessLine

Center-Right Owned by The Hindu Group (Kasturi & Sons)

Trade-margin cap on cancer drugs may push up costs elsewhere in supply chain: Experts

Trade-margin cap on cancer drugs may push up costs elsewhere in supply chain: Experts

RSS excerpt

The Centre said the proposed trade margin cap could cut MRP of anti-cancer drugs by about 20% to 70%

✦ Single Source 1 news outlet reporting

Fact-Check & Bias Analysis

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Coverage Bias Distribution

Based on 1 reporting publisher
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 1 (100%)

Read more news

See all latest stories →